| Title |
Depot pipotiazine palmitate and undecylenate for schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2004
|
| DOI | 10.1002/14651858.cd001720.pub2 |
| Pubmed ID | |
| Authors |
Mohandas Dinesh, Anthony David, Seema N Quraishi |
| Abstract |
Antipsychotic drugs are usually given orally but compliance may be problematic. The development of depot injections in the 1960s gave rise to their extensive use as a means of long-term maintenance treatment. Pipotiazine palmitate is a depot from the phenothiazine family of antipsychotic drugs. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 43% |
| United States | 1 | 14% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 57% |
| Practitioners (doctors, other healthcare professionals) | 2 | 29% |
| Science communicators (journalists, bloggers, editors) | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Colombia | 1 | <1% |
| Unknown | 122 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 18 | 15% |
| Student > Bachelor | 14 | 11% |
| Student > Master | 13 | 10% |
| Student > Ph. D. Student | 11 | 9% |
| Student > Postgraduate | 8 | 6% |
| Other | 23 | 19% |
| Unknown | 37 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 43 | 35% |
| Psychology | 17 | 14% |
| Nursing and Health Professions | 10 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Sports and Recreations | 2 | 2% |
| Other | 8 | 6% |
| Unknown | 39 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 December 2021.
All research outputs
#4,620,492
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#6,806
of 11,499 outputs
Outputs of similar age
#9,445
of 59,870 outputs
Outputs of similar age from Cochrane database of systematic reviews
#14
of 37 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 59,870 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.